Wall Street analysts predict that Merit Medical Systems, Inc. (NASDAQ:MMSI) will post earnings per share (EPS) of $0.30 for the current quarter, according to Zacks. Four analysts have issued estimates for Merit Medical Systems’ earnings. The lowest EPS estimate is $0.28 and the highest is $0.31. Merit Medical Systems reported earnings of $0.26 per share in the same quarter last year, which would indicate a positive year over year growth rate of 15.4%. The company is scheduled to announce its next earnings results on Wednesday, October 25th.

On average, analysts expect that Merit Medical Systems will report full-year earnings of $1.26 per share for the current financial year, with EPS estimates ranging from $1.25 to $1.27. For the next fiscal year, analysts expect that the company will report earnings of $1.42 per share, with EPS estimates ranging from $1.40 to $1.45. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, topping the consensus estimate of $0.29 by $0.07. The firm had revenue of $186.50 million for the quarter, compared to analyst estimates of $181.46 million. Merit Medical Systems had a return on equity of 9.78% and a net margin of 4.87%. Merit Medical Systems’s revenue for the quarter was up 23.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.26 EPS.

A number of analysts have commented on the company. Canaccord Genuity reiterated a “buy” rating and issued a $45.00 price objective on shares of Merit Medical Systems in a research report on Sunday. Zacks Investment Research downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Piper Jaffray Companies restated a “buy” rating and set a $45.00 target price on shares of Merit Medical Systems in a research report on Friday, July 28th. Raymond James Financial, Inc. reiterated an “outperform” rating and issued a $44.00 price objective on shares of Merit Medical Systems in a research report on Monday, August 28th. Finally, UBS AG downgraded Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research report on Monday, August 28th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $41.27.

TRADEMARK VIOLATION NOTICE: “Brokerages Expect Merit Medical Systems, Inc. (MMSI) to Post $0.30 EPS” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/11/brokerages-expect-merit-medical-systems-inc-mmsi-to-post-0-30-eps.html.

Shares of Merit Medical Systems (NASDAQ MMSI) traded down 0.23% during trading on Wednesday, hitting $43.55. The company’s stock had a trading volume of 77,269 shares. The company has a market capitalization of $2.18 billion, a P/E ratio of 63.12 and a beta of 1.25. The firm’s 50 day moving average is $41.89 and its 200-day moving average is $36.96. Merit Medical Systems has a 1-year low of $20.70 and a 1-year high of $45.50.

In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of the company’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $42.06, for a total transaction of $28,180.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director A Scott Anderson sold 25,000 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $41.15, for a total value of $1,028,750.00. Following the sale, the director now owns 10,400 shares of the company’s stock, valued at $427,960. The disclosure for this sale can be found here. Insiders have sold 67,106 shares of company stock worth $2,772,344 in the last three months. 5.00% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Municipal Employees Retirement System of Michigan lifted its stake in shares of Merit Medical Systems by 1.6% in the 1st quarter. Municipal Employees Retirement System of Michigan now owns 13,170 shares of the medical instruments supplier’s stock valued at $380,000 after acquiring an additional 210 shares during the last quarter. LS Investment Advisors LLC increased its holdings in Merit Medical Systems by 8.1% in the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after purchasing an additional 277 shares during the period. Arizona State Retirement System increased its holdings in Merit Medical Systems by 1.3% in the first quarter. Arizona State Retirement System now owns 23,244 shares of the medical instruments supplier’s stock valued at $672,000 after purchasing an additional 300 shares during the period. Louisiana State Employees Retirement System increased its holdings in Merit Medical Systems by 1.5% in the second quarter. Louisiana State Employees Retirement System now owns 20,300 shares of the medical instruments supplier’s stock valued at $774,000 after purchasing an additional 300 shares during the period. Finally, Aperio Group LLC increased its holdings in Merit Medical Systems by 3.9% in the second quarter. Aperio Group LLC now owns 10,467 shares of the medical instruments supplier’s stock valued at $399,000 after purchasing an additional 391 shares during the period. Hedge funds and other institutional investors own 89.11% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.